Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Depreciation & Amortization (CF) (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Depreciation & Amortization (CF) data on record, last reported at $71000.0 in Q1 2013.

  • For Q1 2013, Depreciation & Amortization (CF) fell 12.35% year-over-year to $71000.0; the TTM value through Mar 2013 reached $268000.0, down 17.79%, while the annual FY2025 figure was $138000.0, 21.59% down from the prior year.
  • Depreciation & Amortization (CF) reached $71000.0 in Q1 2013 per SNOA's latest filing, up from $61000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $113000.0 in Q1 2011 and bottomed at $61000.0 in Q4 2012.
  • Average Depreciation & Amortization (CF) over 4 years is $82416.7, with a median of $82000.0 recorded in 2011.
  • Peak YoY movement for Depreciation & Amortization (CF): decreased 7.78% in 2011, then decreased 28.32% in 2012.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $97000.0 in 2010, then fell by 18.56% to $79000.0 in 2011, then dropped by 22.78% to $61000.0 in 2012, then rose by 16.39% to $71000.0 in 2013.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $71000.0 in Q1 2013, $61000.0 in Q4 2012, and $63000.0 in Q3 2012.